SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-12-002537
Filing Date
2012-05-15
Accepted
2012-05-15 14:10:30
Documents
11
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT slxcf_10q.htm 10-Q 530162
2 CERTIFICATION slxcf_ex311.htm EX-31.1 15593
3 CERTIFICATION slxcf_ex312.htm EX-31.2 16047
4 CERTIFICATION slxcf_ex321.htm EX-32.1 6624
5 CERTIFICATION slxcf_ex322.htm EX-32.2 7491
  Complete submission text file 0001354488-12-002537.txt   1884543

Data Files

Seq Description Document Type Size
6 slxcf-20120331.xml EX-101.INS 187111
7 slxcf-20120331.xsd EX-101.SCH 12962
8 slxcf-20120331_cal.xml EX-101.CAL 39277
9 slxcf-20120331_lab.xml EX-101.LAB 92818
10 slxcf-20120331_pre.xml EX-101.PRE 70203
11 slxcf-20120331_def.xml EX-101.DEF 8933
Mailing Address 544 EGERTON ST LONDON A6 N5W 3Z8
Business Address 544 EGERTON ST LONDON A6 N5W 3Z8 519-434-1540
STELLAR PHARMACEUTICALS INC (Filer) CIK: 0001159019 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31198 | Film No.: 12843286
SIC: 2834 Pharmaceutical Preparations